Leveraging mRNA Technology Workshop - 1st Edition
Related Enduring Materials
Day 2 - Friday, 28 April 2023
About this Program
The inaugural edition of the Leveraging mRNA Technology Workshop successfully took place on 27 - 28 April 2023.
The rapid development of mRNA COVID-19 vaccines is an unprecedented success for medicine and it heralds a new era in the development of vaccines for other (infectious) diseases.
The benefits and utility of this technology became quickly clear amongst academic research groups, public health as well as government agencies. Extensive clinical trials have confirmed the safety and efficacy of mRNA vaccines, and the principles of this technology have the potential to be applied to a wide range of other (infectious) diseases.
This might revolutionize the prevention and treatment of, for instance, cancer and many high priority infectious diseases (e.g., malaria, tuberculosis, and HIV), where other vaccine platforms have not been successful.
Compared to other vaccine platforms, mRNA vaccines show robust immune responses and have the potential to be designed and manufactured rapidly. However, there are still questions to be answered, for example regarding the durability of immunity provided.
The advances of mRNA vaccines come together with educational needs to comprehend technology, properties, benefits/limitations, applications to other diseases, and recent clinical data.
The program encompassed the pathway from target discovery and validation to (early) clinical development and use; and included mRNA modifications and delivery methods.
Program Directors
General Information
- Researchers from the pharmaceutical and biotech industry.
- Raise awareness, promote understating and stimulate discussion on the clinical application of mRNA technology
- Provide a global platform to foster cross-disciplinary interaction and knowledge exchange on the mRNA technology, its current clinical applications, and prospects
- Stimulate scientific interchange in an expert, independent and translational setting
- Summarize the latest advancement in mRNA and lipid nanoparticle biotechnology
- Reflect on the latest advancement in design and pre-clinical evaluations of novel vaccine candidates
- Describe clinical data supporting the use of mRNA-based vaccines for infectious diseases
- Comprehend key clinical considerations for the use of mRNA-based therapeutics in different populations and healthcare settings
- Reflect on prospects and limitations of mRNA-based vaccines for infectious diseases and beyond
Practical Information
Washington Marriott Georgetown
1221 22nd Street, NW
Washington D.C. 20037
United States
Distance from Ronald Reagan Washington National Airport (DCA): 4.5 miles
Distance from Washington Dulles International Airport (IAD): 28 miles
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Fees and Conditions
Regular Delegates* |
Industry** |
|
Standard Fee (payment before/ on 23 April 2023) |
Free Registration |
$395.00 |
Onsite Fee / Post-Meeting Fee (payment from 24 April 2023) |
Free Registration |
$795.00 |
Discounts |
|
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates |
Free Registration |
Members of Endorsers |
Free Registration |
Sponsors |
Contact the Secretariat |
*Registration is free for the following participants: NGO Representatives, Advocates, Community Representatives, Policy Makers/ Government Representatives or Healthcare Professionals. Healthcare practitioners are defined as professionals that provide any type of health care service to patients living with HIV or other diseases.
**Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at Michelle.Wu@amededu.com
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Access to all scientific sessions;
- Conference pack, including the program;
- Refreshments during the coffee breaks
For virtual attendees only:
- Access to all scientific sessions;
- Digital workshop pack, including the program;
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Cancellation before/on 31 March 2023 : 50% refund (minus an administration fee of €40)
- Cancellation after 31 March 2023: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 15 April 2023. A statement (email/letter) of cancellation must be sent to Virology Education.
1. Proof of accreditation
2. Valid identification (e.g., passport)
3. A letter from your assignment giver stating the details of your assignment (e.g., editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A discounted registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@virology-education.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Program Directors
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Moderna has provided funding for this Independent Medical Education program.
Moderna has had no input into the selection of speakers or the content of the materials and presentations.
Become an Endorser
If you would like your organization to support this mRNA Workshop as an endorser or media partner, please contact Ms. Michelle Wu at Michelle.Wu@amededu.com.
Endorsers
The Leveraging the mRNA Technology Workshop 2023 is endorsed by the following organizations:
Venue
The confirmed venue details for the Leveraging mRNA Technology Workshop 2023 can be found below.
- Venue: Washington Marriott Georgetown
- Website: https://www.marriott.com/en-us/hotels/waswe-washington-marriott-georgetown/overview/
- Address: 1221 22nd Street NW, Washington, DC 20037, United States (please click here to view the map).
- Distance from Ronald Reagan Washington National Airport (DCA): 4.5 miles
- Distance from Washington Dulles International Airport (IAD): 28 miles
In case you have any questions or concerns regarding the venue, please feel free to contact us at Michelle.Wu@amededu.com.
Group Photo
Promo Video
Health & Safety Measures regarding COVID-19
Ensuring the health and safety of our attendees, suppliers, and staff is our absolute number one priority. In order to provide a safe conference environment, all hybrid and live events organized by Virology Education will follow the national health and safety measures of the country where the meeting is being held in. We kindly ask that all attendees carefully abide by these measures to assist us in ensuring a safe environment for all.
National Health & Safety Measures
The health and safety measures that will be taken by Virology Education during the Leveraging the mRNA Technology Workshop 2023 are listed on the government website of the United States. Please read them very carefully before traveling to the conference venue. These measures will be reviewed in accordance with the evolution of the pandemic.
Our staff will be available onsite to address any questions or concerns that you might have. If you have any questions in advance, please contact the Conference Secretariat at Michelle.Wu@amededu.com.
Traveling to the United States
Virology Education strongly advises participants to check the government website of the United States for the latest and most accurate information about the rules regarding travel.
Please be aware of measures such as testing requirements, vaccination requirements, whether your country of origin is mentioned on the Red List, etc.
What if I get ill during the event?
Should an attendee become ill or exhibit COVID-19 symptoms at any time during the event, the attendee will safely withdraw from the event venue and immediately notify the event organizer with details of other attendees which have been in close contact at the event. By registering for the event, the attendee declares, acknowledges, and accepts that they will comply with all local government requirements should they become ill or exhibit COVID-19 symptoms during the event.